Moreover, luteolin was able to arrest A172 and U87-MG cell cycles in the G2/M phase, an effect correspondingly seen with treatments performed in p53 wildtype colon cancer cells (LoVo cell line) [79]. The gene discussed is TP53; the disease is malignant colon neoplasm.